The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subgroup analysis by prior anti-VEGF or anti-EGFR target therapy in FRESCO, a randomized, double-blind, phase 3 trial comparing fruquintinib versus placebo plus best supportive care in Chinese patients with metastatic colorectal cancer (mCRC).
 
Ruihua Xu
No Relationships to Disclose
 
Jin Li
No Relationships to Disclose
 
Yu-Xian Bai
No Relationships to Disclose
 
Yanhong Deng
No Relationships to Disclose
 
Lei Yang
No Relationships to Disclose
 
Haijun Zhong
No Relationships to Disclose
 
Zhendong Chen
No Relationships to Disclose
 
Hongming Pan
No Relationships to Disclose
 
Weijian Guo
No Relationships to Disclose
 
Yongqian Shu
No Relationships to Disclose
 
Ying Yuan
No Relationships to Disclose
 
Jianming Xu
No Relationships to Disclose
 
Lin Shen
No Relationships to Disclose
 
Ning Wang
Employment - Lilly
 
Xin Wang
Employment - Lilly
 
Haidong Chi
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Patents, Royalties, Other Intellectual Property - Lilly
 
Jack Peng
Employment - Hutchison MediPharma
 
Ye Hua
Employment - Hutchison MediPharma
Leadership - Hutchison MediPharma
Stock and Other Ownership Interests - Hutchison MediPharma
Travel, Accommodations, Expenses - Hutchison MediPharma
 
Weiguo Su
Employment - Hutchison MediPharma
Leadership - Hutchison MediPharma
Stock and Other Ownership Interests - Hutchison MediPharma
Travel, Accommodations, Expenses - Hutchison MediPharma
 
Shukui Qin
No Relationships to Disclose